In the present study, occupancy of SHP and DNMT3A and DNA methylation at the lipogenic genes were substantially reduced in NAFLD patients, although hepatic protein levels of DNMT3A and SHP expression are unchanged. The gene discussed is DNMT3A; the disease is metabolic dysfunction-associated steatotic liver disease.